Contact
Please use this form to send email to PR contact of this press release:
Oncology Pharma Signs Letter of Intent to Acquire a Significant Stake in Diagnomics, Inc.
TO:
Please use this form to send email to PR contact of this press release:
Oncology Pharma Signs Letter of Intent to Acquire a Significant Stake in Diagnomics, Inc.
TO: